Nurse Practitioner, Psychiatric/Mental Health · Long Beach, CA
NPI
1225565104
Since 2017
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4525 E Atherton St
Long Beach, CA, 90815
Phone (562) 961-0155
Groups this clinician bills Medicare through
Medicare paid, 2022
$5,936
147 services
Medicare patients, 2022
30
Average age 59
Drug cost, 2024
$819K
5,492 prescriptions
Company payments, 2025
$467
From 8 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Sherwin Imperio was code 99213 (office e&m - established), 116 times for 23 patients. In total Sherwin Imperio billed 147 services in 3 codes, and Medicare paid $5,936.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 116 | 23 | $40.32 | $4,677 |
Medicare prescription drug claims, 2024
In 2024, the drug Sherwin Imperio prescribed most often to Medicare patients was Clozapine, with 430 prescriptions and refills. In total Sherwin Imperio wrote 5,492 Medicare prescriptions that cost $819K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clozapine Generic | 430 | 432 | 22 | $36K |
| Quetiapine Fumarate Generic | 378 | 392 | 34 | $8,621 |
| Benztropine Mesylate Generic | 347 | 360 | 34 | $4,282 |
| Olanzapine Generic | 302 | 303 | 23 | $4,375 |
| Aripiprazole Generic | 258 | 268 | 32 | $9,107 |
| Sertraline Hcl Generic | 249 | 277 | 29 | $1,804 |
| Trazodone Hcl Generic | 214 | 214 | 25 | $2,001 |
| Hydroxyzine Pamoate Generic | 200 | 200 | 32 | $1,686 |
| Haloperidol Generic | 162 | 162 | 16 | $8,366 |
| Divalproex Sodium Er Divalproex Sodium | 155 | 155 | 14 | $6,690 |
| Olanzapine Odt Olanzapine | 151 | 151 | 14 | $14K |
| Risperidone Generic | 150 | 166 | 23 | $2,084 |
| Gabapentin Generic | 149 | 151 | 15 | $1,599 |
| Clonazepam Generic | 138 | 140 | 20 | $854 |
| Bupropion Xl Bupropion Hcl | 126 | 142 | 14 | $3,101 |
Brand drugs: 272 claims; generic drugs: 5,220 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherwin Imperio $467 ($467 in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $190.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $190 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $62.48 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $48.34 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $48.21 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $39.61 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $38.3 |
| Abbvie Inc. ABBV | 1 | $26.08 |
| Novo Nordisk Inc NVO | 1 | $13.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.